Dirk Lehnick

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 14

Top Venues

Spinal cord

Pharmacology research & perspectives

Disability and rehabilitation. Assistive technology

Antibiotics (Basel, Switzerland)

University of Lucerne

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Lucerne

Switzerland

Head Biostatistics and Methodology :: Dept. of Health Sciences and Medicine

Publications

Anneke Hertig-Godeschalk, Anke Scheel-Sailer, Yannick Wey, Claudio Perret, Dirk Lehnick, Jörg Krebs, Andreas Jenny, Joelle L Flueck
Prevalence of an insufficient vitamin D status at the onset of a spinal cord injury - a cross-sectional study. Spinal cord 61 (3) (2022)
Anneke Hertig-Godeschalk, Anke Scheel-Sailer, Yannick Wey, Claudio Perret, Dirk Lehnick, Jörg Krebs, Andreas Jenny, Joelle L Flueck
Prevalence of an insufficient vitamin D status at the onset of a spinal cord injury - a cross-sectional study. Spinal cord (2022)
Anneke Hertig-Godeschalk, Anke Scheel-Sailer, Yannick Wey, Claudio Perret, Dirk Lehnick, Jörg Krebs, Andreas Jenny, Joelle L Flueck
Prevalence of an insufficient vitamin D status at the onset of a spinal cord injury - a cross-sectional study. Spinal cord 61 (3) (2022)
Judith J W van Beek, Dirk Lehnick, Manuela Pastore-Wapp, Simona Wapp, Christian P Kamm, Tobias Nef, Tim Vanbellingen
Tablet app-based dexterity training in multiple sclerosis (TAD-MS): a randomized controlled trial. Disability and rehabilitation. Assistive technology (2022)
Anneke Hertig-Godeschalk, Anke Scheel-Sailer, Yannick Wey, Claudio Perret, Dirk Lehnick, Jörg Krebs, Andreas Jenny, Joelle L Flueck
Prevalence of an insufficient vitamin D status at the onset of a spinal cord injury - a cross-sectional study. Spinal cord 61 (3) (2022)
Ernst Christiaanse, Patrik O Wyss, Anke Scheel-Sailer, Angela Frotzler, Dirk Lehnick, Rajeev K Verma, Markus F Berger, Alexander Leemans, Alberto De Luca
Mean kurtosis-Curve (MK-Curve) correction improves the test-retest reproducibility of diffusion kurtosis imaging at 3 T. NMR in biomedicine (2022)
Stefanie Deininger, Julia Küppers, Dirk Lehnick, Peter Esslinger, Hermann Winiker, Markus Lehner
Endoscopic third ventriculostomy: a feasible treatment option for pediatric hydrocephalus in a high-risk cohort - a single-center report. World journal of pediatric surgery 5 (3) (2022)
Anneke Hertig-Godeschalk, Anke Scheel-Sailer, Yannick Wey, Claudio Perret, Dirk Lehnick, Jörg Krebs, Andreas Jenny, Joelle L Flueck
Prevalence of an insufficient vitamin D status at the onset of a spinal cord injury - a cross-sectional study. Spinal cord (2022)
Anneke Hertig-Godeschalk, Anke Scheel-Sailer, Yannick Wey, Claudio Perret, Dirk Lehnick, Jörg Krebs, Andreas Jenny, Joelle L Flueck
Prevalence of an insufficient vitamin D status at the onset of a spinal cord injury - a cross-sectional study. Spinal cord 61 (3) (2022)
Marie Heyne-Pietschmann, Dirk Lehnick, Johannes Spalinger, Franziska Righini-Grunder, Michael Buettcher, Markus Lehner, Martin Stocker
Newborns with Bloody Stools-At the Crossroad between Efficient Management of Necrotizing Enterocolitis and Antibiotic Stewardship. Antibiotics (Basel, Switzerland) 10 (12) (2021)
Stefanie Brunner, Jule Liesenberg, Lana Fourie, Jürg Metzger, Andreas Scheiwiller, Irin Zschokke, Dirk Lehnick, Jörn-Markus Gass
Implementation of a Bundle of Care in Colorectal Surgery to Reduce Surgical Site Infections Successfully at Cantonal Hospital Lucerne: Study Protocol for a Prospective Observational Study. International journal of surgery protocols 25 (1) (2021)
Lorena M Bitzi, Dirk Lehnick, Einar P Wilder-Smith
Small fiber neuropathy: Swiss cohort characterization. Muscle & nerve 64 (3) (2021)
Hendrik Wessels, Dirk Lehnick, Josef Höfler, Ruediger Jankowsky, Paul Chamberlain, Karsten Roth
Pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects. Pharmacology research & perspectives 7 (5) (2019)
Karsten Roth, Dirk Lehnick, Hendrik Wessels, Josef Höfler, Barbara Gastl, Ruediger Jankowsky
Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects. Pharmacology research & perspectives 7 (5) (2019)

Dirk Lehnick.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dirk Lehnick